Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity

Autoimmunity Reviews

Volumn 14, Issue 4, 2015, Pages 352-357

  Berti, Alvise ^a,b   Campochiaro, Corrado ^a,b   Cavalli, Giulio ^a,b   Pepe, Gino ^b   Praderio, Luisa ^b   Sabbadini, Maria Grazia ^a,b   Dagna, Lorenzo ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Brachial GCA; Claudication FDG PET; Extracranial GCA; Large vessel GCA; Limb restricted GCA

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CHOLESTEROL; FERRITIN; FLUORODEOXYGLUCOSE F 18; METHOTREXATE; PREDNISONE; TRIACYLGLYCEROL;

ADULT; AGED; ANEMIA; BLOOD CELL COUNT; BLOOD VESSEL BIOPSY; BRACHIAL ARTERY; CASE REPORT; CLAUDICATION; COLOR ULTRASOUND FLOWMETRY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DIABETES MELLITUS; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; FEVER; GIANT CELL ARTERITIS; HEADACHE; HUMAN; HYPERESTHESIA; HYPERGAMMAGLOBULINEMIA; HYPERTENSION; HYPESTHESIA; IMMUNOSUPPRESSIVE TREATMENT; LEG ARTERY; LIMB RESTRICTED GIANT CELL ARTERITIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PARESTHESIA; POSITRON EMISSION TOMOGRAPHY; REVIEW; RHEUMATIC POLYMYALGIA; SYSTOLIC HEART MURMUR; TEMPORAL ARTERY; WEIGHT REDUCTION; ANGIOGRAPHY; AORTA; ARTERY; BIOPSY; CLASSIFICATION; CYTOLOGY; ECHOGRAPHY; LIMB; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VASCULARIZATION;

AGED; ANGIOGRAPHY; AORTA; ARTERIES; BIOPSY; BLOOD SEDIMENTATION; EXTREMITIES; FEMALE; GIANT CELL ARTERITIS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 84923007062     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.12.005     Document Type: Review

References (30)

1. Weyand C.M., Goronzy J.J. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med Jul. 2014, 371(1):50-57.
2. Borchers A.T., Gershwin M.E. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev May 2012, 11(6-7):A544-A554.
3. Alvarez-Rodriguez L., Muñoz Cacho P., Lopez-Hoyos M., Beares I., Mata C., Calvo-Alen J., et al. Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: a cumulative meta-analysis. Autoimmun Rev Oct. 2011, 10(12):790-792.
4. Sammaritano L.R. Menopause in patients with autoimmune diseases. Autoimmun Rev May 2012, 11(6-7):A430-A436.
5. Ly K.-H., Régent A., Tamby M.C., Mouthon L. Pathogenesis of giant cell arteritis: more than just an inflammatory condition?. Autoimmun Rev Aug. 2010, 9(10):635-645.
6. Brack W.C.A., Martinez-Taboada V., Stanson A., Goronzy J.J. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999, 42(2):311-317.
7. Nuenninghoff D.M., Hunder G.G., Christianson T.J.H., McClelland R.L., Matteson E.L. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50years. Arthritis Rheum Dec. 2003, 48(12):3522-3531.
8. Prieto-González S., Arguis P., García-Martínez A., Espígol-Frigolé G., Tavera-Bahillo I., Butjosa M., et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis Jul. 2012, 71(7):1170-1176.
9. Zerizer I., Tan K., Khan S., Barwick T., Marzola M.C., Rubello D., et al. Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol Mar. 2010, 73(3):504-509.
10. Narváez J., Narváez J.A., Nolla J.M., Sirvent E., Reina D., Valverde J. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) Apr. 2005, 44(4):479-483.
11. Meller J., Strutz F., Siefker U., Scheel A., Sahlmann C.O., Lehmann K., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging May 2003, 30(5):730-736.
12. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., de Groot K., Gross W., et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis Mar. 2009, 68(3):318-323.
13. Basu N., Watts R., Bajema I., Baslund B., Bley T., Boers M., et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis Oct. 2010, 69(10):1744-1750.
14. Dasgupta B., Borg F.A., Hassan N., Alexander L., Barraclough K., Bourke B., et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) Aug. 2010, 49(8):1594-1597.
15. Prieto-González S., Depetris M., García-Martínez A., Espígol-Frigolé G., Tavera-Bahillo I., Corbera-Bellata M., et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. Ann Rheum Dis Jul. 2014, 73(7):1388-1392.
16. Kermani T.A., Matteson E.L., Hunder G.G., Warrington K.J. Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. J Rheumatol Oct. 2009, 36(10):2277-2283.
17. Ninet J.P., Bachet P. Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica. Am J Med 1990, 88(January):13-20.
18. Le Hello C., Lévesque H. Lower limb giant cell arteritis and temporal arteritis: followup of 8 cases. J Rheumatol 2001, 28(6).
19. Czihal M., Piller A., Schroettle A., Kuhlencordt P.J., Schulze-Koops H., Hoffmann U. Outcome of giant cell arteritis of the arm arteries managed with medical treatment alone: cross-sectional follow-up study. Rheumatology (Oxford) Feb. 2013, 52(2):282-286.
20. Schmidt W.A., Seifert A., Gromnica-Ihle E., Krause A., Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) Jan. 2008, 47(1):96-101.
21. Amann-Vesti B.R., Koppensteiner R., Rainoni L., Pfamatter T., Schneider E. Immediate and long-term outcome of upper extremity balloon angioplasty in giant cell arteritis. J Endovasc Ther Apr. 2003, 10(2):371-375.
22. Mahr A., Saba M., Kambouchner M., Polivka M., Baudrimont M., Brochériou I., et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?. Ann Rheum Dis Jun. 2006, 65(6):826-828.
23. Taylor-Gjevre R., Vo M., Shukla D., Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol 2005, 32(7).
24. Achkar A., Lie J. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis. Ann Intern Med 1994, 987-992.
25. Narváez J., Bernad B., Roig-Vilaseca D., García-Gómez C., Gómez-Vaquero C., Juanola X., et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum Aug. 2007, 37(1):13-19.
26. Lie J.T. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum Jun. 1995, 24(6):422-431.
27. Mahr A.D., Jover J.A., Spiera R.F., Hernández-García C., Fernández-Gutiérrez B., Lavalley M.P., et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum Aug. 2007, 56(8):2789-2797.
28. Martínez-Taboada V.M., López-Hoyos M., Narvaez J., Muñoz-Cacho P. Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis. Autoimmun Rev Aug. 2014, 13(8):788-794.
29. Both M., Ahmadi-Simab K., Reuter M., Dourvos O., Fritzer E., Ullrich S., et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis Jul. 2008, 67(7):1030-1033.
30. Papathanasiou N.D., Du Y., Menezes L.J., Almuhaideb A., Shastry M., Beynon H., et al. 18F-fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiol Jun. 2012, 85(1014):e188-e194.